Comprehensive assessment of the genomic landscape of breast cancer brain metastases reveals targetable alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

被引：0
|
作者：
Giannoudis, Athina
Sokol, Ethan
Ramkissoon, Shakti H.
Bhogal, Talvinder
McGregor, Kimberly
Clark, Allison
Razis, Evangelia D.
Bartsch, Rupert
Huang, Richard S. P.
Palmieri, Carlo
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-PD4-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD4-09
引用
收藏
页数：3
相关论文
共 48 条
  • [31] Longitudinal immune and genomic monitoring reveals signatures of response and Immune-related adverse events in cancer patients receiving checkpoint inhibitor therapy
    Khan, Shaheen
    Gerber, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors
    Incorvaia, Lorena
    Madonia, Giorgio
    Corsini, Lidia Rita
    Cucinella, Alessandra
    Brando, Chiara
    Gagliardo, Cesare
    Santoni, Matteo
    Fanale, Daniele
    Inno, Alessandro
    Fazio, Ivan
    Foti, Giovanni
    Galia, Massimo
    Badalamenti, Giuseppe
    Bazan, Viviana
    Russo, Antonio
    Gori, Stefania
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [33] Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis
    Wang, Nanya
    Qin, Yong
    Du, Furong
    Wang, Xiaoxuan
    Song, Chao
    GENE, 2022, 834
  • [34] SINGLE-CELL MAPPING OF HUMAN BREAST CANCER BRAIN METASTASES REVEALS PROGNOSTICALLY RELEVANT IMMUNE LANDSCAPES
    Jassowicz, Lena
    Wong, John
    Soller, Julia
    Sor, Furkan
    Feng, Fangyoumin
    Barthel, Mandy
    Unterberg, Andreas
    Lichter, Peter
    Warta, Rolf
    Zapatka, Marc
    Seiffert, Martina
    Herold-Mende, Christel
    NEURO-ONCOLOGY, 2023, 25
  • [35] COMPREHENSIVE GENOMIC AND IMMUNE PROFILING OF NON-SMALL CELL LUNG CANCER BRAIN METASTASES REVEALS LOW TUMOR INFLAMMATION AND ELEVATED CANCER TESTIS ANTIGEN BURDEN
    Seager, R. J.
    Pabla, Sarabjot
    Achyut, B. R.
    Nesline, Mary
    Kannan, Geoffrey
    Chenn, Anjen
    Zhang, Shengle
    Klein, Roger
    Conroy, Jeffrey
    Sausen, Mark
    Saini, Kamal
    Jensen, Taylor
    Reddy, Prasanth
    Severson, Eric
    Ramkissoon, Shakti
    NEURO-ONCOLOGY, 2022, 24 : 4 - 4
  • [36] Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
    S. Y. Cindy Yang
    Scott C. Lien
    Ben X. Wang
    Derek L. Clouthier
    Youstina Hanna
    Iulia Cirlan
    Kelsey Zhu
    Jeffrey P. Bruce
    Samah El Ghamrasni
    Marco A. J. Iafolla
    Marc Oliva
    Aaron R. Hansen
    Anna Spreafico
    Philippe L. Bedard
    Stephanie Lheureux
    Albiruni Razak
    Vanessa Speers
    Hal K. Berman
    Alexey Aleshin
    Benjamin Haibe-Kains
    David G. Brooks
    Tracy L. McGaha
    Marcus O. Butler
    Scott V. Bratman
    Pamela S. Ohashi
    Lillian L. Siu
    Trevor J. Pugh
    Nature Communications, 12
  • [37] Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
    Yang, S. Y. Cindy
    Lien, Scott C.
    Wang, Ben X.
    Clouthier, Derek L.
    Hanna, Youstina
    Cirlan, Iulia
    Zhu, Kelsey
    Bruce, Jeffrey P.
    El Ghamrasni, Samah
    Iafolla, Marco A. J.
    Oliva, Marc
    Hansen, Aaron R.
    Spreafico, Anna
    Bedard, Philippe L.
    Lheureux, Stephanie
    Razak, Albiruni
    Speers, Vanessa
    Berman, Hal K.
    Aleshin, Alexey
    Haibe-Kains, Benjamin
    Brooks, David G.
    McGaha, Tracy L.
    Butler, Marcus O.
    Bratman, Scott, V
    Ohashi, Pamela S.
    Siu, Lillian L.
    Pugh, Trevor J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [38] Outcomes of Immune-Checkpoint Inhibitors (ICIs) and Stereotactic Radiosurgery (SRS) in Non-Small Cell Lung Cancer Brain Metastases (NSCLCBM) Patients
    Tatineni, V.
    O'Shea, P. J.
    Rauf, Y.
    Jia, X.
    Murphy, E. S.
    Chao, S. T.
    Suh, J. H.
    Peereboom, D.
    Ahluwalia, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E581 - E582
  • [39] Landscape of immune-cell signatures in early high-risk breast cancer (BC) reveals clinically-relevant enrichment of immune subpopulations
    Szeto, Christopher
    Denkert, Carsten
    Fasching, Peter A.
    Benz, Stephen
    Weber, Karsten E.
    Budczies, Jan
    Schneeweiss, Andreas
    Stickeler, Elmar
    Schmatloch, Sabine
    Jackisch, Christian
    Karn, Thomas
    Sinn, Hans P.
    Warm, Mathias
    van Mackelenbergh, Marion
    Rabizadeh, Shahrooz
    Schem, Christian
    Heinmoller, Ernst
    Muller, Volkmar
    Marme, Frederik
    Soon-Shiong, Patrick
    Nekljudova, Valentina
    Loibl, Sibylle
    Untch, Michael
    CANCER RESEARCH, 2020, 80 (04)
  • [40] Comprehensive ctDNA profiling reveals potential metastatic genomic signatures in treatment-naive early-stage breast cancer patients
    Shafi, Gowhar
    Dongare, Manoj
    Bharde, Atul
    Fauzul, Moubeen
    Hariramani, Kanchan
    D'Souza, Alain
    Jadhav, Bhagwat
    Kad, Trupti
    Prajapati, Sangeeta
    Jadhav, Vikas
    Kumaran, ManojKumar
    Haldar, Sumit
    Mehra, Vatsal
    Joshi, Sujit
    Aland, Gourishankar
    Dave, Richa
    Jayant, Sreeja
    Vasudevan, Aravindan
    Uttarwar, Mohan
    Khandare, Jayant
    CANCER RESEARCH, 2023, 83 (02)
12345